Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1007 of 6351
-
New hope for Crohn's: Long-Term drug study shows promise
Disease control OngoingThe reason for this study is to determine the long-term efficacy and safety of the study drug mirikizumab in participants with Crohn's disease.
Phase 3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Mindfulness vs. heroin: brain scans may reveal who recovers
Disease control CompletedIn this study, neuroimaging of reward processing, drug cue reactivity and inhibitory control is used before and immediately after 8 weeks of two types of group therapy in individuals with opioid addiction; clinical outcomes will be assessed before, immediately and three months af…
Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
New hope for rare nerve tumor disorder: Multi-Drug trial launches
Disease control Recruiting nowThis is a multi-arm phase II platform-basket screening study designed to test multiple experimental therapies simultaneously in patients with NF2-related schwannomatosis (NF2-SWN, formerly known as neurofibromatosis type 2) with associated progressive tumors of vestibular schwann…
Phase 2 • Sponsor: Scott R. Plotkin, MD, PhD • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Common antidepressant may shield cancer patients from chemo nerve damage
Prevention OngoingThis phase II/III trial studies the best dose of duloxetine and how well it works in preventing pain, tingling, and numbness (peripheral neuropathy) caused by treatment with oxaliplatin in patients with stage II-III colorectal cancer. Duloxetine increases the amount of certain ch…
Phase 2/3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Prevention
Last updated Jun 27, 2026 08:14 UTC
-
Immunotherapy before surgery shows promise for tough skin cancers
Disease control OngoingThis phase II trial studies how well cemiplimab before surgery works in treating patients with skin cancer that is high-risk and has not spread to other parts of the body (localized), has come back locally (locally recurrent), or has spread regionally (regionally advanced), and c…
Phase 2 • Sponsor: University of Southern California • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New combo therapy shows promise for rare cancer
Disease control OngoingThe researchers are doing this study to find out whether combining the study drugs palbociclib and INCMGA00012 is an effective and safe treatment for advanced liposarcoma. "Funding Source - FDA OOPD"
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
DNA-Guided immunotherapy trial aims to match drug to tumor
Disease control Recruiting nowThis study will investigate the effects of atezolizumab on select cancer types in people whose analysis of tumour DNA and RNA indicates they may be sensitive to atezolizumab. This study aims to determine if the information from the cancer genome analysis corresponds with the effe…
Phase 2 • Sponsor: British Columbia Cancer Agency • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Local health workers may hold key to treating epilepsy in african children
Disease control CompletedAbout half of the world's children with epilepsy do not receive treatment - known as the epilepsy treatment gap - with significantly higher rates (67%-90%) in low- and middle-income countries (LMICs). We will conduct the first cluster-randomized clinical trial (cRCT) to determine…
Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Smart radiation therapy could make stem cell transplants safer for Non-Cancer patients
Disease control Recruiting nowThis phase I/II trial studies the best dose of total body irradiation with astatine-211 BC8-B10 monoclonal antibody for the treatment of patients with nonmalignant diseases undergoing hematopoietic cell transplant. Radiation therapy uses high energy gamma rays to kill cancer cell…
Phase 1/2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug shows promise for Long-Term control of back pain condition
Disease control CompletedThe purpose of the study is to demonstrate the long-term safety, tolerability and efficacy of bimekizumab in patients with active axial spondyloarthritis (axSpA, also known as radiographic axSpa (r-axSpA)) including ankylosing spondylitis (AS) and nonradiographic axial spondyloar…
Phase 3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Sep 09, 2026 23:00 UTC
-
New hope for AF patients: device may replace blood thinners after brain bleed
Disease control Recruiting nowAtrial fibrillation is the most common cardiac arrhythmia. In atrial fibrillation, there is a risk that clots can form in the heart, especially in the left atrium. If these clots come loose, there is a risk of stroke. To prevent strokes, patients with atrial fibrillation and stat…
Sponsor: Jena University Hospital • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Can a glowing dye reveal a Woman's fertility after ovarian cyst surgery?
Diagnosis CompletedTo evaluate the feasibility of using Indocyanine Green in the laparoscopic surgical treatment of benign organic ovarian cysts (dermoid, serous, mucinous and endometriotic) in patients with a short-term desire for pregnancy. The use of Indocyanine Green during this surgery could a…
Sponsor: University Hospital, Clermont-Ferrand • Aim: Diagnosis
Last updated Aug 09, 2026 00:00 UTC
-
New eczema drug shows promise in Long-Term safety trial
Disease control CompletedThis is designed to assess the long-term safety and efficacy of lebrikizumab for moderate-to-severe atopic dermatitis. It will last up to 33 months.
Phase 3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Could inhaled gases help COVID-19 patients breathe easier and survive?
Disease control OngoingPatients suffering lung failure, possibly from COVID-19 or hypoxic lung failure, will need life-saving support from a breathing machine. Any patient needing this support requires drugs to keep them sleepy, or "sedated" to be comfortable on this machine. Sedation is made possible …
Phase 3 • Sponsor: Sunnybrook Health Sciences Centre • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New combo therapy aims to shrink melanoma before surgery
Disease control OngoingThe purpose of this study is to test the effects of anti-PI-1 inhibitor (TSR-042) or anti-PD-1/anti-TIM-3 combination (TSR-042 / TSR-022) in patients with operable melanoma.
Phase 2 • Sponsor: Diwakar Davar • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New MRI clue could slash MS misdiagnosis rates
Diagnosis OngoingThe need for improved diagnostic methods in Multiple Sclerosis (MS) is widely recognized. Although Magnetic Resonance Imaging (MRI) is a longstanding tool for detecting MS lesions, diagnostic inaccuracies persist. Up to 20% of people diagnosed with MS (1 in 5) are later found not…
Sponsor: The Cleveland Clinic • Aim: Diagnosis
Last updated Jun 27, 2026 07:52 UTC
-
Could cheap heart drugs save lives from pesticide poisoning?
Disease control CompletedThis study evaluates whether the addition of intravenous magnesium sulphate or nimodipine to standard therapy (supportive care plus for all patients atropine and, for OP insecticide poisoned patients, pralidoxime) benefits patients after acute anticholinesterase self-poisoning wi…
Phase 3 • Sponsor: University of Edinburgh • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Could a week of antibiotics stop joint infections after replacement surgery?
Disease control By invitation onlyTo determine the effectiveness of a 7-day course of an oral, prophylactic antibiotic on the incidence of periprosthetic joint infection and wound complications following primary total hip and knee arthroplasty in a high-risk patient population.
Phase 4 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New hope for hard-to-treat lymphoma: targeted drug combo tested in large trial
Disease control OngoingThe participants of this study would have relapsed/refractory follicular lymphoma. Follicular lymphoma is a type of blood cancer. It is referred to as 'relapsed' when the disease has come back after a period of improvement after that follows a treatment regimen and 'refractory' …
Phase 3 • Sponsor: Epizyme, Inc. • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
New drug combo shows promise against resistant ovarian cancer
Disease control CompletedAfuresertib is an AKT inhibitor, a new class of agents under development that may provide physicians with a new clinical option to control platinum resistant ovarian cancer (PROC) progression. Afuresertib plus chemotherapy has demonstrated anti-tumor efficacy and an acceptable sa…
Phase 2 • Sponsor: Laekna Limited • Aim: Disease control
Last updated Jun 26, 2026 15:45 UTC